Aescap Venture
Signal active
Investment Firm
Overview
N/A
Highlights
Founded
2005
Industry
Venture Capital
Employees
11-50
Investment
28
Lead Investment
9
Exits
6
Stages
Early Stage Venture, Late Stage Venture, Private Equity
Investor Type
Venture Capital
Location
Europe
Contact Information
Social
Profile Resume
Aescap Venture, established in 2005 and headquartered in Europe., specializes in Early Stage Venture, Late Stage Venture, Private Equity investments across Biotechnology, Pharmaceutical, Chemical, Renewable Energy, Financial Services, Venture Capital, Finance, Asset Management, Banking, Therapeutics. The organization boasts a portfolio of 28 investments, with an average round size of $20.4M and 6 successful exits. Their recent investments include Avantium, Capricorn Partners, ING Group, Vivendy Therapeutics, TVM Capital. The highest investment round they participated in was $40.2B. Among their most notable exits are Avantium and Capricorn Partners. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
Aescap Venture has made 28 investments. Their most recent investment was on Nov 20, 2020, when F-Star Therapeutics raised $15.0M.
investments
28
Diversity investments
0
Lead investments
9
Number of exits
6
Investments
28
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| May 22, 2015 | i-Optics | Biotechnology | 15.1M |
| Mar 08, 2017 | Orphazyme | Biotechnology | 14.8M |
| Nov 16, 2017 | Orphazyme | Biotechnology | 94.2M |
| Nov 20, 2020 | F-Star Therapeutics | Biotechnology | 15.0M |
i-Optics
Orphazyme
F-Star TherapeuticsExits
6
Funding Timeline
Funding rounds
28
Investors
0
Funds
2
Funding Rounds
28
Aescap Venture has raised 28 rounds. Their latest funding was raised on Nov 20, 2020 from a Post-IPO Equity - F-Star Therapeutics round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| May 22, 2015 | Venture Round - i-Optics | - | 15.1M | - |
| Mar 08, 2017 | Venture Round - Orphazyme | - | 14.8M | - |
| Nov 16, 2017 | Venture Round - Orphazyme | - | 94.2M | - |
| Nov 20, 2020 | Post-IPO Equity - F-Star Therapeutics | - | 15.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.